Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Crescita Therapeutics Inc (CRRTF)

Crescita Therapeutics Inc (CRRTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Crescita Reports 2019 Third Quarter Results

Revenue up 9.9% Year-over-Year Positive Adjusted EBITDA1 of $0.9 Million

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Crescita Reports 2019 Third Quarter Results

Revenue up 9.9% Year-over-Year Positive Adjusted EBITDA 1  of $0.9 Million

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita"), a commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare products and prescription...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®

LAVAL, QC , Nov. 5, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita"), a commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) ("Crescita"), a Canadian commercial dermatology company,...

CRRTF : 0.7000 (-1.20%)
SNDL : 3.88 (+2.11%)
CTX.TO : 0.96 (+3.23%)
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

CALGARY and LAVAL, QC, Oct. 28, 2019 /PRNewswire/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX and OTC US:...

SNDL : 3.88 (+2.11%)
CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

CALGARY and LAVAL, QC , Oct. 28,  2019 /PRNewswire/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX) and (OTC...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
SNDL : 3.88 (+2.11%)
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

NEW YORK, NY / ACCESSWIRE / September 5, 2019 / Crescita Therapeutics Inc. (TSX:CTX)(OTC Pink:CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

LAVAL, QC , Sept. 5, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Crescita Reports Profitable 2019 Second Quarter Results

Record Revenue of $9.4 Million and Adjusted EBITDA of $5.1 Million

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Crescita Reports Profitable 2019 Second Quarter Results

Record Revenue of $9.4 Million and Adjusted EBITDA of $5.1 Million

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Knight Announces Early Warning Filing Regarding Disposition of Shares of Crescita

This press release is being disseminated by Knight Therapeutics Inc. ("Knight") (TSX:GUD), a specialty pharmaceutical company, as required by National Instrument 62-103 - The Early Warning System and Related...

CRRTF : 0.7000 (-1.20%)
GUD.TO : 8.22 (-0.24%)
United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis®

Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis®

LAVAL, QC , July 16, 2019 /PRNewswire/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Crescita Therapeutics to Host Investor Webcast on July 24, 2019

LAVAL, QC , July 11, 2019 /PRNewswire/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription...

CTX.TO : 0.96 (+3.23%)
CRRTF : 0.7000 (-1.20%)
Crescita Therapeutics to Host Investor Webcast on July 24, 2019

Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of EUR1.25 Million Following First Commercial Sale of Pliaglis by Cantabria in Italy

Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)
Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of €1.25 Million Following First Commercial Sale of Pliaglis by Cantabria in Italy

LAVAL, QC , July 4, 2019 /PRNewswire/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription...

CTX.TO : 0.96 (+3.23%)
CRRTF : 0.7000 (-1.20%)
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") announced today that the Toronto Stock Exchange (the "TSX") has approved the Company's intention to make a normal course...

CRRTF : 0.7000 (-1.20%)
CTX.TO : 0.96 (+3.23%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.30 , AIZ -0.99 , SBAC +0.16 , SO -0.79 , WELL +0.23
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar